搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Axios on MSN
11 小时
GSK sues Moderna over mRNA vaccine technology
GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...
1 天
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...
WXYZ
28 分钟
British drugmaker sues Moderna for patent infringement related to mRNA vaccines
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
BioSpace
8 小时
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
4 小时
GSK claims Moderna infringed mRNA vaccine patents
The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 ...
pharmaphorum
14 小时
GSK turns its guns on Moderna in mRNA jab patent dispute
The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it acquired Novartis' global vaccine business in 2015. Only by tapping into ...
The Global Legal Post
6 小时
GSK sues Moderna over Covid and RSV vaccines
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...
1 天
GSK就mRNA专利权起诉Moderna
英国制药公司葛兰素史克(GlaxoSmithKline)在特拉华州的一家联邦法院对美国Moderna公司提起诉讼。GSK声称Moderna在开发和销售其COVID-19疫苗Spikevax的过程中侵犯了GSK与信使RNA(mRNA)技术相关的专利。 该诉讼声称,Moderna用于将mRNA传递到细胞中的脂质纳米粒子侵犯了GSK的专利。根据GSK的说法,这些专利是Moderna疫苗产品所使用的mRN ...
The Pharma Letter
10 小时
GSK files lawsuit against Moderna
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...
FiercePharma
22 小时
GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...
大众网
9 小时
葛兰素史克(GSK.US)称RSV疫苗保护作用可持续三个季度
智通财经APP获悉,葛兰素史克 (GSK.US)周二表示,其呼吸道合胞病毒 (RSV)疫苗在接种后的三个季度都具有保护作用。经季节性因素调整后的数据显示,这种用于老年人的疫苗的三个季度累积有效性为62.9%。
devdiscourse
22 小时
Patent Wars: GSK Takes on Moderna Over mRNA Innovations
GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈